tirzepatide dual agonist Lighting up targets of therapies for diabetes and obesity Is retatrutide better than tirzepatide?

If you have diabetes or pre-diabetes, they may ask for blood tests to help guide your care

Heres what you need to know about the Dr

What are your favorite music festivals

The Bottom Line Retatrutide is the most pharmacologically ambitious weight loss drug to reach human trials, and its 24% average body weight reduction at 48 weeks is legitimately impressive

This tells your brain youve already ovulated

June 18 Product: AbbVies Skyrizi Indication: Ulcerative colitis AbbVies blockbuster therapy Skyrizi now has further reach after the FDA greenlit the IL-23 antagonist for the treatment of moderately to severely active ulcerative colitis